← Leaderboards
Rafat Ali Siddiqui
Clarian Health Partners, Inc.
$507,952
Attributed
$507,952
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $67.5K · FY2009–24$100K$75K$50K$25K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$507,952 · 4
By mechanism
R01$245,753 · 1
R03$135,000 · 1
P20$127,199 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyCell LineSignal PathwayTumorInnovationMalignant NeoplasmsMolecularMediatingPreventiveDietary ComponentPathway InteractionsPreventEffective TherapyBaseInflammationDifferential ExpressionAntineoplastic AgentsAnti-Inflammatory AgentsCancer Health DisparityEfficacy EvaluationCancer EtiologyCancer CenterDatabasesChronic
Grant awards (7)
Pilot Project 1$789
P20 · FY2024 · CA · contact PI
Pilot Project 1$41,851
P20 · FY2023 · CA · contact PI
Pilot Project 1$41,853
P20 · FY2022 · CA · contact PI
Pilot Project 1$42,706
P20 · FY2021 · CA · contact PI
Synergistic anticancer effects of docosahexanoic acid and curcumin$67,500
R03 · FY2010 · CA · contact PI
Synergistic anticancer effects of docosahexanoic acid and curcumin$67,500
R03 · FY2009 · CA · contact PI
Angiogenesis in the Pulmonary Microvasculature$245,753
R01 · FY2004 · HL